TG Therapeutics

The crucial data readouts coming soon for small biotechs
EP Vantage
Thu, 04/23/20 - 12:37 pm
clinical trials
Akebia
Blueprint Medicines
Genfit
TG Therapeutics
vadadustat
Ayvakit
elafibranor
Biotech's Most Volatile Binary Events for Q1
Motley Fool
Fri, 01/3/20 - 10:24 am
FDA
Esperion Therapeutics
Karyopharm
TG Therapeutics
Heron Therapeutics
TG aims for accelerated approval of lymphoma candidate
BioCentury
Fri, 03/1/19 - 09:37 am
TG Therapeutics
umbralisib
TGR-1202
lymphoma
The Most Promising Biotech Names Heading Into 2019
Investopedia
Mon, 12/31/18 - 12:18 pm
biotech
AbbVie
Novavax
Amarin
TG Therapeutics
3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019
Motley Fool
Wed, 12/12/18 - 09:59 am
TG Therapeutics
Madrigal Pharmaceuticals
Puma Biotechnology
TG stock sinks after setback to blood cancer trial
Fierce Biotech
Tue, 09/25/18 - 09:59 am
TG Therapeutics
FDA
ublituximab-umbralisib
CLL
chronic lymphocytic leukemia
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Mon, 08/13/18 - 11:26 am
TG Therapeutics
Sangamo Therapeutics
Akcea Therapeutics
FDA
Waylivra
umbralisib
SB-913
ASCO 2018 Sends TG Therapeutics Stock Soaring 10% Today
Motley Fool
Mon, 06/4/18 - 09:55 pm
TG Therapeutics
umbralisib
chronic lymphocytic leukemia
ASCO 2018
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Fri, 04/20/18 - 12:45 pm
Incyte
TG Therapeutics
Cara Therapeutics
CR845
opioids
ublituximab
leukemia
olumiant
rheumatoid arthritis
Data from trials could send these clinical-stage biotech stocks soaring or crashing
Motley Fool
Mon, 02/5/18 - 08:26 am
clinical trials
biotech
Summit Therapeutics
DMD
Jounce Therapeutics
JTX-2011
TG Therapeutics
ublituximab
3 Best Biotech Stocks During Trump's First 100 Days
Motley Fool
Tue, 05/2/17 - 10:04 am
biotech stocks
Donald Trump
Esperion Therapeutics
Aurinia Pharmaceuticals
TG Therapeutics
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
Endpoints
Mon, 03/6/17 - 09:47 am
TG Therapeutics
ublituximab
TG-1101
FDA
CLL
8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls
24/7 Wall St
Mon, 05/30/16 - 10:05 am
GW Pharma
Integra LifeSciences
Minerva Neurosciences
Neurocrine Biosciences
Teladoc
TG Therapeutics
Asterias
Innocoll GmbH
2 Small Biotech Stocks Poised For Substantial Upside
Seeking Alpha
Fri, 04/22/16 - 10:41 am
biotech
pSivida
TG Therapeutics
The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
24/7 Wall St
Tue, 12/30/14 - 10:21 am
Agios Pharmaceuticals
OvaScience
Radius
Prosensa
TG Therapeutics
Bluebird Bio
Receptos
Best and worst 2014 biotech performers on Wall Street
Fierce Biotech
Tue, 12/23/14 - 10:24 am
Avanir Pharmaceuticals
Agios Pharmaceuticals
TG Therapeutics
Bluebird Bio
Vivus
Agerion
Theravance
Interim Data From Phase 1 Dose Escalation Clinical Trial of TGR-1202, the Once-Daily PI3K Delta Inhibitor, Demonstrates Significant Clinical Activity and Lack of Hepatic Toxicity in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Non-H
Yahoo/Globe NewsWire
Sun, 12/7/14 - 10:04 am
TGR-1202
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
TG Therapeutics
3 Newsworthy Biotech Stocks: BioDelivery, CytRx, TG Therapeutics
Wall St Cheat Sheet
Mon, 02/3/14 - 10:55 am
BioDelivery Sciences
TG Therapeutics
CytRx
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Forbes
Mon, 05/27/13 - 08:17 pm
Biogen Idec
Rituxan
TG Therapeutics
Utuxin
TGR-1202
CLL
chronic lymphocytic leukemia
non-Hodgkin's lymphoma

Pages